New drug shows promise for rare hormone disorder in early trial
Disease control
Completed
This study tested a new medicine called SPR001 in 24 adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal was to see if the drug is safe and can help control the disease by lowering certain hormone levels. Partic…
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 17, 2026 11:37 UTC